http://www.thevaccinereaction.org/2018/05/how-nih-uses-u-s-tax-dollars-to-secure-profits-for-vaccine-developers-and-manufacturers/

It is no secret that huge conflicts of interest exist between vaccine promoters and vaccine makers. Pediatrician and vaccine developer Paul Offit, for example, who is one of the nation’s leading promoters of mandatory use of government recommended vaccines, holds a $1.5 million research chair at Children’s Hospital in Philadelphia, funded in part by Merck.¹ Julie Gerberding left her post as Director of the Centers for Disease Control and Prevention (CDC), where she oversaw the creation of national vaccine policies, to head Merck vaccines.² Former Texas governor Rick Perry recommended state-wide inoculation of all 11- and 12-year-old girls with Merck’s Gardasil vaccine after his chief of staff left to work at Merck.^{3 4}

Just as disturbing are the millions of dollars that officials at the National Institutes of Health (NIH) dole out to academic institutions and vaccine manufacturers to improve vaccine technology, find new, lucrative markets and boost vaccine marketability—functions that guarantee the profitability of corporations, but do not always ensure the well being of taxpayers, the public and patients.

Once upon a time, before passage of the Bayh-Dole Act by Congress in 1980 and the push for lucrative “technology transfer” business arrangements between federal agencies and for-profit corporations, inventions developed with federal funding were owned by the U.S. Government and not industry. Today, taxpayer-supported research to develop new drugs and vaccines is voraciously patented by universities and drug companies for outsized Wall Street profits when the research rightfully belongs to taxpayers.⁵

Development of the human papillomavirus (HPV) Gardasil and Cervarix vaccines is a case in point. The initial research was funded by the NIH, National Cancer Institute, University of Rochester, Georgetown University and the University of Queensland, which licensed them to Merck and GlaxoSmithKline.^{6 7} In 2015, Merck made $1.9 billion on its Gardasil franchise.⁸

Soon, aggressive domestic and overseas marketing of the expensive HPV vaccines began, even as the vaccines themselves got poor marks for both safety and effectiveness. In 2006, consumer advocacy groups had protested the FDA’s fast tracking of Gardasil vaccine to licensure, citing inadequate safety data.⁹ Reports of sudden collapse/fainting (syncope) and serious neurological and immune system problems after Gardasil vaccinations emerged immediately after the vaccine was licensed.¹⁰

(more)

https://www.activistpost.com/2018/05/cdc-study-150-increase-in-autism-in-u-s-kids-since-2000-researchers-suspect-environmental-risks-and-triggers-2012-research-determined-wifi-radiation-disrupts-blood-brain-barrier-may-cause-leaki.html

By B.N. Frank

According to an April 26, 2018 Bloomberg article,

“Nationally, the prevalence (of autism) has increased 150 percent since 2000, according to the study, which called autism “an urgent public-health concern.”

and

“Researchers aren’t sure what causes autism, although they suspect environmental risks or triggers.”

Bloomberg must have interviewed the wrong researchers.  There is actually government, independent, industry, and military research that has already proven that cell phone and wireless WiFi radiation as well other sources of Electrical Pollution (Electrosmog) are “environmental risks and triggers” for many health issues – behavioral, emotional, mental and physical.

By Catherine J. Frompovich

https://www.activistpost.com/2018/05/cervical-cancer-increases-since-hpv-vaccines-per-swedish-study.html

It seems there are more “correlation and causation” effects from vaccines, especially with the much-touted ‘cervical cancer prevention’ vaccines known as Gardasil®, Gardasil 9® and Cervarix® – the Human Papillomavirus (HPV) vaccines manufactured by Merck & Company and GlaxoSmithKline, respectively!

These vaccines are loaded with aluminum adjuvants.

Source: CDC

Gardasil®
Each 0.5-mL dose of the vaccine contains approximately 225 mcg of aluminum (as Amorphous
Aluminum Hydroxyphosphate Sulfate adjuvant), 9.56 mg of sodium chloride, 0.78 mg of L-histidine,
50 mcg of polysorbate 80, 35 mcg of sodium borate, <7 mcg yeast protein/dose, and water for injection.
The product does not contain a preservative or antibiotics.

Source: Merck (PDF, Pg. 12)

Gardasil 9®
Each 0.5-mL dose of the vaccine also contains approximately 500 mcg of aluminum (provided as
AAHS), 9.56 mg of sodium chloride, 0.78 mg of L-histidine, 50 mcg of polysorbate 80, 35 mcg of sodium
borate, <7 mcg yeast protein, and water for injection. The product does not contain a preservative or
antibiotics.

Source: Merck  (PDF, Pg. 11)

Cervarix® (Recombinant, AS04 adjuvanted)
This AS04 adjuvant system comprises aluminium hydroxide (Al(OH)3) and 3-O-desacyl-4’-
monophosphoryl lipid A (MPL). (Pg. 1)

Note that under the Description, no amount in mcg or otherwise is listed for the aluminum content!

Genotoxicity The genotoxic potential of CERVARIX has not been investigated. (Pg. 15)

Carcinogenicity The carcinogenic potential of CERVARIX has not been investigated. (Pg. 16)

Source: GlaxoSmithKline PDF

Even though the GlaxoSmithKline package insert for Cervarix® seemingly skirts stating the amount of aluminum in the GSK HPV vaccine, I was able to find the content of aluminum hydroxide on the European Union health documents website below and it is 0.5 milligrams!

Cervarix suspension for injection

Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed)
2adjuvanted by AS04 containing:  3-O-desacyl-4’- monophosphoryl lipid A (MPL)3 50 micrograms 
3adsorbed on aluminium hydroxide, hydrated (Al(OH)3) 0.5 milligrams Al3+ in total

Source: Europa (PDF, Pg. 2)

The Indian Journal of Medical Ethics Online first published the Comment article “Increased incidence of cervical cancer in Sweden: Possible link with HPV vaccination” April 30, 2018 DOI:10.20529/IJME.2018.037.

According to the Abstract for the article by Lars Andersson,

The Centre for Cervical Cancer Prevention in Sweden has noted in its annual report a substantial increase in the incidence of invasive cervical cancer, especially during the two years 2014 and 2015.  [….]

The increase in the incidence of cervical cancer was shown to be most prominent among women 20–49 years of age while no apparent increase was observed among women above 50.

I [Andersson] discuss the possibility that HPV vaccination could play a role in the increase in the incidence of cervical cancer by causing instead of preventing cervical cancer disease in women previously exposed to HPV. A time relationship exists between the start of vaccination and the increase in the incidence of cervical cancer. The HPV vaccines were approved in 2006 and 2007, respectively and most young girls started to be vaccinated during 2012–2013.

Lars Andersson is associated with the prestigious Karolinska Institute [1].

In the Introduction section of the Andersson article, he cites and translates “The Centre for Cervical Cancer Prevention (NKCx) in Sweden has noted in its annual report of 2017(1), which includes data up to 2016,” as follows:

The age-standardised incidence of invasive cervical cancer in Sweden has increased substantially in the last two years (20%) and there is a statistically significant increase for the entire period 2005–2015. The incidence in Sweden for 2014–2015 is 11.5 per 100,000 women. The increase in the last two years can be seen in all counties except Södermanland, Skåne, Jämtland and Västerbotten. Substantial and statistically significant increases are seen for Östergötland, Jönköping, Blekinge, Halland, Värmland, Örebro and Dalarna, with an average yearly increase of 7%–8%. Tendencies of substantial increases are also seen for Uppsala, Gotland, Västmanland and Västerbotten with yearly average increases of 4% or more.

[CJF emphasis]

https://www.cnn.com/2018/04/26/health/autism-prevalence-cdc/index.html

One in 59 US children has autism, according to a new report from the US Centers for Disease Control and Prevention. The new estimate represents a 15% increase from two years prior and a 150% increase since 2000. Autism spectrum disorder, a developmental disability, is characterized by problems with communication and social interaction with accompanying repetitive behavior patterns. The CDC launched the Autism and Developmental Disabilities Monitoring Network in 2000 to collect data that would provide estimates of the prevalence of autism spectrum disorder and other developmental disabilities. The agency … developed a methodology for estimating autism prevalence using information from children’s health and education records. The new estimated rate of autism in the United States is based on data collected from 11 communities in Arizona, Arkansas, Colorado, Georgia, Maryland, Minnesota, Missouri, New Jersey, North Carolina, Tennessee and Wisconsin. About 8% of all 8-year old children living in the US [live in these communities]. Overall, fewer than half of the children identified with autism had received their first diagnosis by the time they were 4 years old, the new CDC report finds. Also, the definition of autism has changed through the decades. In the past, more than half of children identified with autism also had intellectual disability, and now it’s about a third.

Note: The above article carefully avoids mentioning the link between autism and environmental toxins such as mercury additives in vaccines. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.